Procurement Summary
Country: USA
Summary: Innovative Approaches to Studying Cancer Communication in the New Media Environment (R21 - Clinical Trial Optional)
Deadline: 13 Jun 2019
Posting Date: 13 Feb 2018
Other Information
Notice Type: Tender
TOT Ref.No.: 20457858
Document Ref. No.: PAR-18-639
Competition: ICB
Financier: Self Financed
Purchaser Ownership: -
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Tender are invited for Innovative Approaches to Studying Cancer Communication in the New Media Environment (R21 - Clinical Trial Optional)
CFDA Number : 93.395 -- Cancer Treatment Research
Cost Sharing or Matching Requirement : No
Closing Date for Applications: Jun 13, 2019
Posted Date : Feb 07, 2018
Description: This Funding Opportunity Announcement (FOA) invites applications that seek to apply one or more innovative methodologies in communication research across the cancer control continuum, from prevention, early detection, diagnosis, treatment, and survivorship, to end of life. Applications to this FOA should utilize one or more of the following analytic approaches, methods, and data sources, including but not limited to social media data mining, Natural Language Processing (NLP) techniques, online social network analysis, crowdsourcing research tools (e.g., mTurk), online search data, Ecological Momentary Assessment, neuroscience and biobehavioral approaches to communication, and geographic information systems. Studies should assess outcomes related to cancer prevention and control (e.g., knowledge, attitudes, beliefs, perceived risk, decision making in screening and treatment, information inequalities, social support, shared decision making, persuasion, caregiving, behavioral intentions, preventive behaviors, and policy support, among others). This FOA utilizes the Exploratory/Developmental Grant (R21) mechanism, which supports investigation of novel scientific ideas or new model systems, tools, or technologies that have the potential for significant impact on biomedical or biobehavioral research. An R21 grant application need not have extensive background material or preliminary information.
Documents
Tender Notice